Searle & Co. Abbott Laboratories Transaction History

Searle & Co.

$390 Million
Q1 2024

A detailed history of Searle & Co. transactions in Abbott Laboratories stock. As of the latest transaction made, Searle & Co. holds 17,300 shares of ABT stock, worth $1.8 Million. This represents 0.5% of its overall portfolio holdings.

Number of Shares

17,300

Previous 17,400 0.57%

Holding current value

$1.8 Million

Previous $1.92 Million 2.66%

% of portfolio

0.5%

Previous 0.53%

13 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 09, 2024	SELL	$109.52 - $120.96 $10,952 - $12,096	-100 Reduced 0.57%	17,300 $1.97 Million
Q4 2023 Feb 05, 2024	BUY	$90.19 - $110.4 $45,095 - $55,200	500 Added 2.96%	17,400 $1.92 Million
Q1 2023 Jun 01, 2023	SELL	$96.86 - $114.01 $48,430 - $57,005	-500 Reduced 2.87%	16,900 $1.71 Million
Q4 2022 Feb 03, 2023	BUY	$95.06 - $111.52 $57,036 - $66,912	600 Added 3.57%	17,400 $1.91 Million
Q2 2022 Aug 03, 2022	SELL	$102.07 - $123.37 $10,207 - $12,337	-100 Reduced 0.59%	16,800 $1.83 Million

Q1 2022 May 10, 2022	BUY	$114.02 - $139.04 $22,804 - $27,808	200 Added 1.2%	16,900 $2 Million
Q4 2021 Jan 19, 2022	SELL	$115.53 - $141.46 $23,106 - $28,292	-200 Reduced 1.18%	16,700 $2.35 Million
Q4 2020 Feb 04, 2021	BUY	$105.0 - $114.42 $10,500 - $11,442	100 Added 0.6%	16,900 $1.85 Million
Q4 2019 Jan 21, 2020	SELL	$78.51 - $87.4 $3,925 - $4,370	-50 Reduced 0.3%	16,800 $1.46 Million
Q3 2019 Oct 22, 2019	BUY	$81.84 - $88.74 $65,472 - $70,992	800 Added 4.98%	16,850 $1.41 Million
Q1 2019 Apr 22, 2019	BUY	$66.22 - $80.06 $13,244 - $16,012	200 Added 1.26%	16,050 $1.28 Million
Q3 2018 Oct 16, 2018	BUY	$60.81 - $73.36 $289,333 - $349,046	4,758 Added 42.9%	15,850 $1.16 Million
Q3 2017 Oct 27, 2017	BUY	$48.06 - $53.64 $533,081 - $594,974	11,092	11,092 $592,000

Others Institutions Holding ABT

# of Institutions

3,130

Shares Held

1.29B

Call Options Held

8.43M

Put Options Held

8.71M

View Full List

About ABBOTT LABORATORIES

Ticker ABT
Exchange NYSE
Sector Healthcare
Industry Medical Devices
Shares Outstandng 1,751,219,968
Market Cap $182B
Description
Abbott Laboratories, together with its subsidiaries, discovers, develops, manufactures, and sells health care products worldwide. It operates in four segments: Established Pharmaceutical Products, Diagnostic Products, Nutritional Products, and Medical Devices. The Established Pharmaceutical Products segment provides generic pharmaceuticals for t...

More about ABT

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Searle & Co., based on Form 13F filings with the SEC.

News

Stay updated on Searle & Co. with notifications on news.

Account